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Abstract  
Calmodulin (CaM) and Ca2+/CaM-dependent protein kinase II (CaMKII) play 
important roles in the development of heart failure. In this study, we evaluated the 
effects of CaM on mitochondrial membrane potential (ΔΨm), permeability transition 
pore (mPTP) and the production of reactive oxygen species (ROS) in permeabilized 
myocytes; our findings are as follows. (1) CaM depolarized ΔΨm dose-dependently, but 
this was prevented by an inhibitor of CaM (W-7) or CaMKII (autocamtide 2-related 
inhibitory peptide (AIP)). (2) CaM accelerated calcein leakage from mitochondria, 
indicating the opening of mPTP, however this was prevented by AIP. (3) Cyclosporin A 
(an inhibitor of the mPTP) inhibited both CaM-induced ΔΨm depolarization and calcein 
leakage. (4) CaM increased mitochondrial ROS, which was related to ΔΨm 
depolarization and the opening of mPTP. (5) Chelating of cytosolic Ca2+ by BAPTA, 
the depletion of SR Ca2+ by thapsigargin (an inhibitor of SERCA) and the inhibition of 
mitochondrial Ca2+ uniporter by Ru360 attenuated the effects of CaM on mitochondrial 
function. (6) CaM accelerated Ca2+ extrusion from mitochondria. We conclude that 
CaM/CaMKII depolarized ΔΨm and opened mPTP by increasing ROS production, and 
these effects were strictly regulated by the local increase in cytosolic Ca2+ concentration, 
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initiated by Ca2+ releases from the SR. In addition, CaM was involved in the regulation 
of mitochondrial Ca2+ homeostasis. 
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1. Introduction 
 In cardiac myocytes, intracellular Ca2+ and calmodulin (CaM) have an 
important role in the regulation of cellular function [1, 2]. After the binding of Ca2+, 
CaM activates Ca2+-calmodulin dependent protein kinase that has several isoforms, of 
which type II (CaMKII) is most abundant in the heart. Both CaM and CaMKII activate 
many cellular targets involved not only in Ca2+ regulation but also in cell metabolism, 
protein kinase, gene expression and cell proliferation, thus serving as ubiquitous second 
messengers [1, 3, 4]. 
 In addition to these physiological roles of CaM/CaMKII, recent studies 
demonstrated that CaM/CaMKII is closely related to the onset and the development of 
heart diseases [3-5]. For example, CaMKII induces myocardial hypertrophy and 
remodeling by phsophorylating and exporting histone deacetylase (HDAC) from the 
cell nucleus [4, 6], causes deleterious effects in irreversible ischemia/reperfusion injury 
[7], and increases the probability of developing arrhythmias [3]. In human heart failure, 
CaMKII expression and CaMKII activity are increased and these changes correlate 
positively with the cardiac function of the patient [1, 4].  
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In heart failure, the increased adrenergic activity contributes to the 
development of contractile dysfunction, and CaMKII is activated by β1-adrenergic 
receptor (β1AR). Activation of CaMKII during acute stimulation of β1AR mediates the 
positive inotropic and relaxant effects of adenylate cyclase-cAMP-protein kinase A 
(PKA) [8]. In contrast, chronic β1AR stimulation induces apoptosis but this was 
prevented not by PKA inhibitors but by CaMKII inhibitors, indicating the involvement 
of the activation of CaM/CaMKII, independently of PKA signaling [2]. Interestingly, 
the anti-apoptotic actions of CaMKII inhibition were mirrored by SR Ca2+ depletion 
induced by thapsigargin (TG), a potent antagonist of SR Ca2+-ATPase [8, 9]. 
Mitochondria are the central organelle for apoptotic cell death signaling, and 
mitochondrial Ca2+ overload occurs after persistent increases in cytosolic Ca2+ 
concentration ([Ca2+]c) [10, 11]. An increase in mitochondrial Ca2+ concentration 
([Ca2+]m) depolarizes mitochondrial inner membrane potential (ΔΨm), produces ROS 
and triggers the mitochondrial permeability transition pore (mPTP) opening [12, 13], 
followed by the subsequent release of apoptogenic proteins into the cytosol [11]. Since 
CaM/CaMKII translates Ca2+ signaling in cardiac myocytes, it is important to 
investigate how CaM/CaMKII regulates mitochondrial function and apoptotic cell death. 
The purposes of this study were 1) to determine the effects of CaM and CaMKII on 
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ΔΨm, mPTP and ROS generation, 2) to clarify whether CaM-induced effects on 
mitochondria are related to intracellular Ca2+ concentration and SR Ca2+ contents, 3) to 
evaluate the effect of CaM on the regulation of mitochondrial Ca2+ homeostasis.  
 We found that CaM/CaMKII depolarized ΔΨm, opened mPTP and increased 
ROS production. These effects of CaM/CaMKII were strictly regulated by the local 
increase in cytosolic Ca2+ concentration, initiated by the Ca2+ releases from the SR. In 
addition, CaM/CaMKII regulated mitochondrial Ca2+ homeostasis by accelerating Ca2+ 
extrusion via mitochondrial Na+/Ca2+ exchanger (mitoNCX). 
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2. Methods 
2.1. Cell isolation and sarcolemmal membrane permeabilization 
This investigation conforms to the Guide for the Care and Use of Laboratory 
Animals Published by the US National Institutes of Health (NIH Publication No. 85-23, 
revised 1996), and the Hamamatsu University School of Medicine Animal Care and Use 
Committee. The isolated myocytes were obtained from male Sprague-Dawley rats 
(250-350 g) as described previously [14, 15]. In short, after the enzymatic dissociation, 
cells were once kept in a modified Kraft-Brühe solution, which contained (mM) 70 
KOH, 40 KCl, 20 KH2PO4, 3 MgCl2, 50 glutamic acid, 10 glucose, 10 HEPES, and 0.5 
EGTA (pH 7.4 with KOH). Just before the experiments, the cells were placed in a 
chamber and perfused with a normal Tyrode solution, composed of (mM) 143 NaCl, 5.4 
KCl, 0.5 MgCl2, 0.25 NaH2PO4, 1 CaCl2, 5.6 glucose and 5 HEPES (pH 7.4 with 
NaOH). For the permeabilization of sarcolemmal membrane, cells were perfused with 
saponin (0.05 mg/ml) in a Ca2+-free internal solution, which contained (mM) 50 KCl, 80 
K-asparate, 4 Na-pyruvate, 20 HEPES, 3 MgCl2-6H2O, 2 Na2ATP, 3 EGTA (pH 7.3 
with KOH). After the sarcolemmal membrane was permeabilized, the concentration of 
free calcium ([Ca2+]c) in the internal solution was increased according to the 
experimental protocol. [Ca2+]c was obtained by mixing EGTA and CaCl2, calculated 
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with a computer program (WINMAXC, provided by Stanford University). All 
experiments were conducted at room temperature (23°C) within 6 hours of cell 
isolation. 
 
2.2. Measurements with confocal imaging 
All measurements were performed with a laser scanning confocal microscope 
(LSM 5 PASCAL, Karl-Zeiss) coupled to an inverted microscope (Axiovert 200M, 
Karl-Zeiss) with a 63× water-immersion objective lens ([NA] =1.2: Karl-Zeiss). 
Mitochondrial membrane potential was measured with a voltage fluorescent indicator, 
tetramethylrhodamine ethyl ester (TMRE). Saponin-permeabilized myocytes were 
loaded with TMRE (10 nM) for 20 min by the continuous perfusion of TMRE in an 
internal solution. As a reference, an uncoupler, 2, 4-dinitorophenol (DNP, 100 μM), was 
applied at the end of the experiments. The opening of mPTP was evaluated by the 
calcein release from the mitochondrial matrix. As we described earlier [15, 16], the 
isolated myocytes were loaded with calcein-AM (1 µM) for 30 min, and then the 
sarcolemmal membrane was permeabilized to remove excessive cytoplasmic dyes. The 
generation of ROS was measured with the fluorescent indicator 2’ 7’-dichlorofluorescin 
diacetate (DCF: 10 μM) or 6-carboxy-2’ 7’-dichlorodihydrofluorescin diacetate, 
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di(acetoxymethyl ester) (C-DCDHF-DA: 5 μM). For the measurement of DCF intensity, 
after the permeabilzation of the membrane, myocytes were continuously perfused with 
10 μM DCF [16]. In C-DCDHF-DA loaded myocyte, cells were loaded with 
C-DCDHF-DA for 30 min and then sarcolemmal membrane was permeabilized [17]. In 
the measurement of [Ca2+]m, myocytes were loaded with rhod-2-AM (20 μM) for 30 
min, and then the sarcolemmal membrane was permeabilized to remove the excessive 
cytosolic rhod-2 dyes [15]. 
TMRE and Rhod-2 were excited at 543 nm with a helium-neon laser, and the 
emission signals were collected through a 560 nm long-pass filter. Calcein was excited 
with an argon laser at 488 nm and emissions were collected through a 505 nm long pass 
filter. DCF and C-DCDHF-DA were excited with an argon laser at 514 nm, and the 
emission signals were collected through a 530 nm long-pass filter. For quantitative 
analysis of the changes in fluorescent intensity, the identical regions of interest (20×20 
pixels) were monitored every 1-5 minutes. In the preliminary experiments, several ROIs 
were set in a single cell and fluorescent signals from each ROI were compared to 
examine spatial heterogeneity and there were small differences in the time courses of 
the changes in signal intensities among these ROIs. 
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2.3. Chemicals  
Calmodulin (CaM), autocamtide 2-related inhibitory peptide (AIP), cyclosporin 
A (CsA), 2, 4-dinitorophenol, 1, 2-Bis (2 aminophenoxy) ethane-N, N, N, N-tetraacetic 
acid tetrasodium salt (BAPTA) and thapsigargin (TG) were purchased from 
Sigma-Aldrich (St. Louis, Missouri, USA). W-7 hydrochloride (W-7), Ru360 and 
Trolox were purchased from Calbiochem-Novabiochem Corp. (La Jolla, California, 
USA). All fluorescent dyes were purchased from Molecular Probes (Eugene, OR, 
USA). 
 
2.4. Data analyses  
Data are presented as means ± SEM, and the number of cells or experiments is 
shown as n. Statistical analyses were performed using two-way ANOVA of repeated 
measurements, followed by Bonferroni test. A level of p < 0.05 was accepted as 
statistically significant. 
11 
3. Results 
3.1. CaM depolarizes mitochondrial membrane potential (ΔΨm) via mPTP opening 
 To investigate the effects of CaM/CaMKII on ΔΨm, saponin-permeabilized 
myocytes were perfused with an internal solution, which contained 177 nM Ca2+ 
([Ca2+]c = 177 nM) and a voltage-sensitive fluorescent dye TMRE (10 nM). Figure 1A 
shows the representative 2-D images of TMRE, which were obtained before, after 40 
min administration, and after the washout of CaM. As shown in Figure 1B, 40 min 
perfusion of CaM (10 nM) significantly depolarized ΔΨm (CaM; 53.4 ± 3.7% of the 
baseline). When cells were pretreated with an inhibitor of CaM (W-7, 100 nM) or an 
inhibitor of CaMKII (AIP, 500 nM), application of CaM (10 nM) under the continuous 
presence of W-7 or AIP inhibited CaM-induced ΔΨm depolarization. It should be 
mentioned that the inhibitory effect of W-7 was less than that of AIP. However, we 
were not able to use higher dose of W-7, because in the preliminary experiment, W-7 
depolarized ΔΨm at the concentration higher than 500 nM. The effects of W-7 and AIP 
indicated that CaM depolarized ΔΨm by activating cellular CaM/CaMKII. In Figure 1C, 
TMRE intensities after 40 min perfusion of CaM (0.1 nM-1000 nM) and CaM (10 nM) 
with W-7 or AIP are summarized. CaM depolarized ΔΨm in a dose-dependent manner 
and inhibitors of CaM (W-7; 80.2 ± 1.2% of the baseline, n = 10, p < 0.05 versus CaM 
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or AIP; 92.3 ± 5.3% of the baseline, n = 6, p < 0.05 versus CaM) attenuated the 
CaM-induced ΔΨm depolarization. 
Since the opening of mPTP depolarizes ΔΨm [18], we investigated the effects 
of an mPTP inhibitor, cyclosporin A (CsA, 200 nM) on the CaM-induced 
depolazization of ΔΨm. Pretreatment of myocytes with CsA (200 nM, for 5 min) 
significantly attenuated CaM-induced ΔΨm depolarization (CsA; 92.5 ± 4.7% of the 
baseline, n = 9, p < 0.05 versus CaM; Figure 1D) suggesting that CaM/CaMKII 
depolarized ΔΨm in a CsA-sensitive manner.   
We have previously reported that the permeabilization of myocytes after the 
loading of calcein-AM enabled localization of fluorescent calcein in mitochondria and 
that calcein signal reduced when the mPTP opened [15, 16]. By using this method, the 
effects of CaM on the mPTP opening were examined. Figure 2A shows the 
representative 2-D images of calcein, recorded before and after the perfusion of CaM. 
As shown in Figure 2B, CaM significantly decreased calcein intensity compared with 
the control (CaM; 73.5 ± 1.9% of the baseline, n = 16, p < 0.05 versus CTL; 90.1 ± 
2.9% of the baseline, n = 18) and this effect was inhibited by CsA (CsA; 88.8 ± 1.9% of 
the baseline, n = 8, p < 0.05 versus CTL). When cells were preincubated with AIP and 
CaM was applied in the presence of AIP, the CaM-induced calcein leakage from 
13 
mitochondria was inhibited by AIP (83.6 ± 1.5% of the baseline, n = 12, p < 0.05 versus 
CaM). These results indicated that the activation of CaM/CaMKII opened the mPTP.  
 
3.2. CaM generates ROS which opens mPTP 
Mitochondria are one of the major sources for the generation of ROS, which is 
a key inducer of the mPTP [13]. To investigate whether CaM increases ROS generation, 
cells were loaded with a ROS sensitive dye, DCF [16] or C-DCDHF-DA [17]. The 2-D 
images of DCF (upper) and C-DCDHF-DA (bottom) obtained before and after the 
perfusion of CaM are shown in Figure 3A. As shown in Figure 3B, the DCF signal 
increased to 8.4 ± 0.7 fold of the baseline (n = 15, p < 0.05 versus control) after the 
perfusion of CaM, and this CaM-induced DCF elevation was inhibited by a ROS 
scavenger Trolox (100 μM) (1.8 ± 0.5 fold of the baseline, n = 6, p < 0.05 versus CaM). 
Since DCF constantly existed in the internal solution and could respond to cytosoic 
ROS (possibly leaked out from mitochondrial matrix), we used acetoxymetyl form of 
DCF (C-DCDHF-DA) and selectively loaded mitochondria to clarify the site of ROS 
generation. In Figure 3C, CaM gradually increased the C-DCDHF-DA signal to 3.0 ± 
0.4 fold of the baseline (n = 5, p < 0.05 versus control), and Trolox (100 μM) inhibited 
CaM-induced C-DCDHF-DA elevation (1.4 ± 0.1 fold of the baseline, n = 8, p < 0.05 
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versus CaM). Pretreatment of AIP attenuated the increases in C-DCDHF-DA by CaM 
(AIP; 1.1 ± 0.1 fold of the baseline, n = 8, p < 0.05 versus CaM). These results indicate 
that ROS generated mainly in the mitochondrial matrix. When cells were pretreated 
with CsA, CaM-induced ROS generation was partially reduced (1.9 ± 0.1 fold of the 
baseline, n = 9, p < 0.05 versus CaM, Figure 3D). 
Next, we investigated the possible links between CaM-induced ROS generation, 
ΔΨm depolarization, and the mPTP opening. As shown in Figures 3E and 3F, 
pretreatment of Trolox prevented CaM-induced ΔΨm depolarization (81.7 ± 3.5% of the 
baseline, n = 8, p < 0.05 versus CaM) and CaM-induced calcein leakage (87.2 ± 1.3% of 
the baseline, n = 11, p < 0.05 versus CaM). These data suggested that CaM/CaMKII 
induced opening of mPTP and depolarization of ΔΨm were related to ROS generated in 
the mitochondrial matrix. 
 
3.3. CaM, intracellular Ca2+, and mitochondrial function 
In the following series of experiments, the involvement of Ca2+ in the effects of 
CaM was examined. When cells were exposed to CaM (10 nM) with a nominal 
Ca2+-free ([Ca2+]c = 0 nM) or a [Ca2+]c = 177 nM internal solutions for 40 min, there 
were no differences in CaM-induced depolarization of ΔΨm between the two groups. (0 
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nM Ca2+; 56.0 ± 6.0% of the baseline, n = 13, 177 nM Ca2+; 53.4 ± 3.7% of the baseline, 
n = 9, Figure 4A solid bars). When BAPTA (5 mM) was added to the solution for the 
complete chelating of Ca2+, the CaM-induced ΔΨm depolarization was attenuated (85.0 
± 2.4 % of the baseline, n = 17, p < 0.05 versus 177 nM Ca2+, Figure 4A). It was also 
shown that BAPTA eliminated CaM-induced calcein leakage from mitochondria (92.4 ± 
1.5% of the baseline, n = 9, p < 0.05 versus 177 nM Ca2+, Figure 4B) and ROS 
generation by CaM (3.4 ± 0.2 fold of the baseline, n = 7, p < 0.05 versus 177 nM Ca2+, 
Figure 4C). These results indicated that at least sub-nanomolar intracellular Ca2+ is 
required for the activation of CaM/CaMKII, which leads to CaM-induced mitochondrial 
ROS generation, the mPTP opening, and ΔΨm depolarization.  
 
3.4. Sarcoplasmic reticulum Ca2+ and the effect of CaM on mitochondrial function 
Previous studies reported a cross-talk of Ca2+ signaling between SR and 
mitochondria [10]. We next investigated the role of Ca2+ releases from the SR on the 
effects of CaM. When cells were pretreated with thapsigargin (TG; 10 μM) for 15 min 
in a nominal Ca2+-free internal solution, the SR Ca2+ content was completely depleted 
(assessed by SR Ca2+ release with caffeine, data not shown). The application of CaM in 
the continuous presence of TG abolished the effects of CaM on ΔΨm (Figure 5A, 85.0 ± 
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2.4% of the baseline, n = 16, p < 0.05 versus without TG, n = 13). TG also attenuated 
both CaM-induced calcein leakage from mitochondria (89.1 ± 3.2 % of the baseline, n = 
11, p < 0.05 versus without TG, n = 15, Figure 5B) and ROS generation by CaM (2.9 ± 
0.2 fold of the baseline, p < 0.05 versus without TG, n = 5, Figure 5C), indicating that 
the SR Ca2+ releases are required to activate CaM/CaMKII and to depolarize ΔΨm. 
CaM-induced depolarization of ΔΨm was also inhibited when the SR Ca2+ release was 
inhibited by ryanodine (supplemental Figure 1A). In contrast, CaM-induced ΔΨm 
depolarization was enhanced in the presence of caffeine (1 mM), which facilitated SR 
Ca2+ release (supplemental Figure 1B). As demonstrated above, (Figures 4A-C), in the 
nominal Ca2+-free internal solution ([Ca2+]c = 0 nM, without BAPTA), CaM depolarized 
ΔΨm as much as that observed in the 177 nM Ca2+ solution. In addition, neither the 
calcein leakage from mitochondria nor the DCF elevation by CaM was abolished when 
cells were perfused with the nominal Ca2+-free internal solution. Taken together, it is 
suggested that the SR Ca2+ load and the local Ca2+ release from the SR play a pivotal 
role in activating CaM/CaMKII and altering mitochondrial function.  
 
3.5. The effects of CaM on mitochondrial function are related to mitochondrial Ca2+ 
uptake 
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A very close coupling of the SR Ca2+ release site and mitochondrial Ca2+ 
uptake within a highly restricted domain [15, 19, 20] implies that Ca2+ released from SR 
could alter [Ca2+]m and mitochondrial function. Since mitochondrial Ca2+ uptake 
depends mainly on a Ca2+ uniporter, we investigated the effect of Ru360, a specific 
inhibitor of mitochondrial Ca2+ uniporter, on CaM-induced mitochondrial function. As 
shown in Figure 6A, the CaM-induced ΔΨm depolarization ([Ca2+]c = 177 nM) was 
partially inhibited by 10 μM Ru360 (68.6 ± 1.3% of the baseline, n = 9, p < 0.05 versus 
CaM). It was also shown that both calcein leakage from mitochondria (83.4 ± 2.0% of 
the baseline, n = 11, p < 0.05 versus CaM, figure 6B) and the increase in DCF (5.5 ± 0.4 
fold of the baseline, n = 10, p < 0.05 versus CaM, figure 6C) induced by CaM were 
partially attenuated by Ru360. These results indicate that mitochondrial Ca2+ uptake was 
involved in CaM-induced changes in mitochondrial function. 
 The opening and closing of mPTP are tightly regulated by mitochondrial 
matrix Ca2+ concentration ([Ca2+]m), and an increase in [Ca2+]m facilitates the opening of 
mPTP [11]. The inhibitory effects of Ru360 on CaM-induced alterations in 
mitochondrial function suggest that the regulation of [Ca2+]m might be affected by CaM. 
To address this, we assessed [Ca2+]m by using a Ca2+ sensitive fluorescent indicator, 
rhod-2-AM, and examined whether exogenous CaM affects [Ca2+]m. In Figure 7A, 2-D 
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images of rhod-2 before and after the application of CaM in a Na+-free internal solution 
are shown. Figure 7B demonstrates the summarized data of rhod-2 intensities after a 20 
min perfusion of CaM (10 nM) under different conditions. Perfusion of CaM with an 
internal solution (177 nM Ca2+ plus 6 mM Na+) slightly, but not significantly, increased 
[Ca2+]m (110.6 ± 3.5% of baseline, n = 13). When the Ca2+ extrusion via mitoNCX was 
inhibited with a Na+-free ([Na+]c = 0 mM) solution [15], [Ca2+]m did not increase 
significantly. However, the application of CaM in the Na+-free and 177 nM Ca2+ 
solution increased rhod-2 intensity significantly (to 150.1 ± 4.1% of baseline, n = 14, p 
< 0.05). It is likely that CaM-induced elevation of [Ca2+]m was cancelled out by the Ca2+ 
extrusion via mitoNCX. When SR Ca2+ releases were abolished by TG, the increase in 
[Ca2+]m by CaM in a Na+-free solution was eliminated (101.9 ± 3.8% of the baseline, n 
= 9, p < 0.05 vs. CaM alone). These results implied that there was a CaM-mediated Ca2+ 
signaling between the SR and mitochondria and that Ca2+ released from the SR was 
immediately taken-up by neighboring mitochondria. Inhibition of mitochondrial Ca2+ 
uptake by Ru360 reduced rhod-2 intensity to 85.3 ± 2.7% of baseline (n = 6, Figure 7C) 
and the application of CaM in the presence of Ru360 further reduced the rhod-2 
intensity to 78.2 ± 3.3% of the baseline, (p<0.05 vs Ru 360 alone, n = 6). From these 
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results, it is suggested that CaM could activate NCX and accelerate Ca2+ extrusion via 
NCX. 
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4. Discussion 
Apoptotic cell death has been implicated as a causative factor in the 
development of cardiac dysfunction, and mitochondrial dysfunction bas been shown to 
participate in the induction of apoptosis. In this study, we investigated the effects of 
CaM/CaMKII on mitochondrial function and mitochondrial Ca2+ regulation in 
chemically-skinned cardiac myocytes, and found that 1) CaM/CaMKII accelerated ROS 
production, opened mPTP, and depolarized ΔΨm, 2) these effects of CaM/CaMKII on 
mitochondrial function were regulated by the local increase in [Ca2+]c, which was 
established by the Ca2+ releases from closely located SR, 3) Ca2+ influx via Ca2+ 
uniporter is involved in the effects of CaM on mitochondrial function, and 4) 
CaM/CaMKII regulated mitochondrial Ca2+ homeostasis by accelerating Ca2+ extrusion 
via mitoNCX. 
 
4.1. The effects of CaM and CaMKII on mitochondrial function in permeabilized 
myocytes 
 CaM is a ubiquitous Ca2+ binding protein and about half of the cellular CaM is 
associated with membranes, especially at Z-lines in cardiac myocytes. While the other 
half is mainly in the cytoplasm and the nucleus, CaM is also identified at mitochondria. 
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Physiologically, the total concentration of CaM ([CaM]) of cardiac myocytes is about 6 
μM, and free [CaM] was estimated to be less than 50 nM [21, 22]. In this study, we 
investigated the effects of CaM/CaMKII on mitochondrial function by applying CaM in 
permeabilized myocytes, where [Ca2+ ]c is controlled, and intracellular architectures, 
such as a close contact between the SR and mitochondria, are minimally perturbed [15, 
16, 19]. The spontaneous Ca2+ releases from the SR were observed as resting Ca2+ 
sparks in our experimental condition (supplemental Figure 2A-E). In the experiments 
using fluorescent dye conjugated CaM, the wash-in of exogenous CaM after 
sarcolemmal permeabilization has two-phase components with time constants of 34 
seconds and 15 minutes [23]. This is in good agreement with our results that the effects 
of exogenously-applied CaM on mitochondrial function appeared within several 
minutes. 
In this study, we used fluorescent dyes to monitor the ΔΨm, the opening mPTP, 
and ROS generation and demonstrated that exogenously-applied CaM depolarized ΔΨm 
dose- dependently (Figure 1C), within the ranges of previously reported physiological 
free [CaM]. It is also shown that CaM accelerated the formation of mitochondrial ROS 
and opened the mPTP. However, it should be considered that the decrease in TMRE 
signal might be overestimated and the increase in ROS signal might be underestimated, 
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respectively, because the opening of mPTP could release dyes from mitochondria. Since 
CaM-induced opening of the mPTP and depolarization of ΔΨm were inhibited by Trolox 
(Figures 3E and 3F), CaM-induced depolarization of ΔΨm and the opening mPTP could 
be attributed, at least in part, to mitochondrial ROS generation. 
Our results that an inhibitor of CaMKII attenuated the effects of CaM on mitochondrial 
function suggest that exogenously-applied CaM activated CaMKII as a downstream 
target in permeablized myocytes. These results are consistent with previous studies, 
which described that β1AR stimulation provoked oxidative stress and that the inhibition 
of CaM or CaMKII protected cells from apoptosis by preventing the accumulation of 
ROS [24-26]. CaM/CaMKII-induced depolarization of ΔΨm reduces ATP supply, and 
this may disturb cellular homeostasis by dysfunctioning cellular ATP dependent 
processes, such as SR Ca2+ uptake. Thus, the energy impairment, as well as mPTP 
opening and apoptotic signaling is critical for the cellular damage induced by 
CaM/CaMKII. 
Although the mechanisms by which CaM/CaMKII increased ROS generation 
are not clear, several hypotheses could be proposed. First, CaM-induced changes in 
[Ca2+]m may have activated Ca2+-dependent dehydrogenases that transfer more electrons 
to the respiratory chain and stimulate oxidative phosphorylation. Second, 
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phosphorylation of several proteins as the down stream targets of Ca2+-CaM/CaMKII, 
such as δ subunit of ATP-synthase and monoamine oxidase located in outer membrane 
of the mitochondria, might have influenced the rate of respiration and the subsequent 
production of ROS [27]. Since the reduction of antioxidant activity, such as by 
glutathione [28], has been reported in Ca2+-exposed mitochondria or in failing hearts, 
CaM-induced alteration of [Ca2+]m homeostasis may also have affected oxidant 
buffering potential, and possibly contributed to the increase in the total amount of 
mitochondrial ROS. In our study, CaM increased mitochondrial ROS generation and 
CsA attenuated this effect of CaM (Figure 3D). This result might indicate CsA inhibited 
mitochondrial ROS-induced ROS release via an mPTP [29]. Further studies are needed 
to clarify the underlying mechanism of CaM/CaMKII-induced ROS generation. 
 
4.2. The effects of CaM and CaMKII on mitochondria are regulated by local Ca2+ 
signaling and Ca2+ influx. 
Our results demonstrated that the removal of Ca2+ from an internal solution (in 
the presence of EGTA) had no apparent impact on CaM-induced ROS generation, 
mPTP opening and ΔΨm depolarization, while the complete quenching of intracellular 
Ca2+ by BAPTA or the depletion of SR Ca2+ by TG abolished the effects of CaM on 
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mitochondrial function. Inhibition of SR Ca2+ release by ryanodine (100 μM) also 
abolished CaM-induced ΔΨm depolarization (supplemental Figure 1A). These suggest 
that the activation of CaM/CaMKII is intrinsically insensitive to the bulk cytosol levels 
of [Ca2+] and requires the high [Ca2+] established by Ca2+ releases from the SR [30]. 
This is further supported by our data that CaM-induced ΔΨm depolarization was 
enhanced in the presence of caffeine (1 mM), which facilitates the SR Ca2+ releases 
(supplemental Figure 1B).  
One consideration is whether Ca2+ release from the SR occurred in our 
experimental conditions, because CaM is known to inhibit SR Ca2+ releasing channel 
(RyR) opening [1]. However, Guo et al have recently reported that CaM decreased 
resting Ca2+ spark frequency dose-dependently, and that half-inhibition was at 100 nM 
CaM (K0.5) in permeabilized mice ventricular myocytes [31]. The concentration of CaM 
used in this study was relatively low compared to this value. Phosphorylation of RyR by 
CaMKII has been shown to increase Ca2+ leakage from the SR [2, 31, 32] and the 
distribution of CaMKII in the SR [33] and the existence of an anchoring protein of 
CaMKII in the SR have been previously demonstrated [34]. Thus, the balance between 
the inhibitory effects of CaM on RyR and the activating effect of CaMKII on the 
opening probability of RyR may determine total Ca2+ released from the SR. 
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Although there is a close contact between mitochondria and RyR, and 
mitochondrial Ca2+ uptake plays a critical role for the Ca2+ signal transduction during 
the exposure to CaM, this is not a solo mechanism for the effects of CaM on 
mitochondria, since the inhibition of Ca2+ uniporter resulted in a partial inhibition of the 
effects of CaM (Figures 6A, B, C). The CaM-binding site on the outer surface of 
mitochondria [35, 36] has been identified, and the CaM binding protein waspurified 
from the matrix of bovine mitochondria [37]. However, the distribution of CaMKII in 
mitochondrial membrane or matrix has not been reported. Taken together, there is a 
possibility that activated CaM directly affects mitochondria-located target proteins and 
induces functional alteration of mitochondria.  
 
4.3. CaM/CaMKII and mitochondrial Ca2+ homeostasis  
Transportation of Ca2+ into mitochondria depends primarily on the uniporter 
and the extrusion of Ca2+ from mitochondria is largely achieved by mitoNCX, and 
previous reports indicated that mitochondrial Ca2+ uptake through the uniporter was 
facilitated by CaM [38, 39]. We observed only a slight increase in [Ca2+]m after the 
application of CaM (Figures 7B). This might be due to the compensated Ca2+ extrusion 
from mitochondria via mitoNCX, because CaM increased [Ca2+]m in a Na+-free internal 
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solution, where [Na+]c dependent Ca2+ efflux via mitoNCX was inhibited [15]. The 
increase in [Ca2+]m was completely inhibited in TG-pretreated cells (Figure 7A). This 
also indicates that the cross-talk of Ca2+ signaling between SR Ca2+ release and 
mitochondrial Ca2+ uptake was affected by CaM. 
It is likely that Ca2+ seems to be extruded from mitochondria via mitoNCX 
even after the complete inhibition of an uniportor (Figure 7C), suggesting that CaM 
activated mitoNCX and enhanced Ca2+ efflux from mitochondria even at relatively low 
concentration of [Ca2+]m.  
 
4.4 Conclusion 
We conclude that CaM/CaMKII opened mPTP and depolarized ΔΨm via the 
acceleration of ROS production in permeabilized rat ventricular myocytes and that these 
effects of CaM/CaMKII on mitochondria were related to high [Ca2+]c established by 
Ca2+ released from SR and to Ca2+ uptake by neighboring mitochondria. In addition, 
CaM/CaMKII regulated mitochondrial Ca2+ homeostasis by increasing Ca2+ influx and 
activating mitoNCX. 
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Figure Legends 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1, CaM depolarizes mitochondrial membrane potential. 
(A) The 2-D images of TMRE, upper left; before CaM, upper right; after 40 min perfusion of CaM, and lower left; 
after the washout of CaM. (B) Time courses of the changes in TMRE intensity. Permeabilized myocytes were 
perfused with a 177 nM Ca2+ internal solution ([Ca2+]c = 177 nM, ○; n = 8), and then CaM (10 nM) was applied in 
the absence (●; n = 9) or presence of W-7 (□; 100 nM, n = 10) or AIP (△; 500 nM, n = 6). In the W-7 or AIP-treated 
group, cells were pretreated with W-7 or AIP for 15 min, and then CaM was applied with the presence of W-7 or AIP. 
As a reference, an uncoupler, DNP (100 μM), was applied at the end of experiments. (C) The summarized data of 
TMRE intensity after 40 min perfusion with a control internal solution (CTL, n = 8), CaM (0.1 nM - 1000 nM, n = 8), 
CaM plus W-7 (n = 10), and CaM plus AIP (n = 6). (D) The same experimental protocol as (B) was conducted in the 
absence (●, n = 9) or presence of CsA (◇; 200 nM, n = 9). In the CsA-treated group, cells were pretreated with CsA 
for 5 min, and then CaM (10 nM) was applied in the presence of CsA. Data are presented as the percentages of 
TMRE intensity before CaM application, and values are means ± SEM. * p < 0.05 vs CaM, † p < 0.05 vs CTL by 
two-way ANOVA and Bonferroni test. 
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Figure 2, CaM opens mitochondrial permeability transition pore. 
(A) The 2-D images of calcein, left; before CaM and right; after the perfusion of CaM. (B) Time courses of the 
changes in calcein intensity during the perfusion of a control internal solution (○; [Ca2+]c = 177 nM, n = 18), CaM 
(●; 10 nM, n = 16), and CaM plus CsA (◇; 200 nM, n = 8). In the CsA-treated group, cells were pretreated with CsA 
for 5 min, and then CaM was applied in the presence of CsA. (C) the same experimental protocol as (B) was 
performed in the absence (●; 10 nM, n = 16) and presence of AIP (△; 500 nM, n = 12). In the AIP-treated group, 
cells were pretreated AIP for 15 min, and then CaM was applied in the presence of AIP. Data are presented as the 
percentages of calcein intensity before CaM application, and values are means ± SEM. * p < 0.05 vs CaM, † p < 0.05 
vs control by two-way ANOVA and Bonferroni test. 
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Figure 3, CaM increases mitochondrial ROS production. 
(A) The 2-D images of DCF (upper) and C-DCDHF-DA (bottom). left; before CaM, right; after the perfusion of CaM 
for 40 min. (B) and (C) Time courses of changes in DCF (B) or C-DCDHF-DA (C) signals during and after the 
perfusion of CaM in the presence of ROS scavenger (Trolox). Cells were perfused with a control internal solution (○; 
[Ca2+]c = 177 nM, n = 5-7), CaM (●; 10 nM, n = 7-15), and CaM plus Trolox (▽; 100 μM, n =6-8). In the 
Trolox-treated group, cells were pretreated with Trolox for 5 min, and then CaM was applied in the presence of 
Trolox. Data are presented as multiples of the baseline before CaM application, and values are means ± SEM. (D) 
Time courses of changes in C-DCDHF-DA signals during and after the perfusion of CaM in the presence of AIP or 
CsA. In the AIP or CsA-treated group, cells were preincubated with AIP (△, 500 nM, n = 8), or CsA (◇, 200 nM, n = 
9) for 15 min, and then CaM was applied in the presence of AIP or CsA. Data are presented as multiples of the 
baseline before CaM application, and values are means ± SEM. (E) and (F) Time courses of changes in TMRE (E) 
and calcein (F) intensity during and after the perfusion of CaM. The same experimental protocol as B or C was 
conducted to measure TMRE and calcein in the absence (●, n = 9-16) or presence of Trolox (▽, 100 μM, n = 8-11) in 
the 177 nM Ca2+ internal solution. Data are presented as the percentages of TMRE or calcein intensity before CaM 
application, and values are means ± SEM. * p < 0.05 vs CaM, by two-way ANOVA and Bonferroni test. 
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Figure 4, Intracellular Ca2+ is required for the effects of CaM on mitochondria.  
(A) The summarized data of TMRE intensity after 40 min perfusion of CaM (10 nM) in the Ca2+-free ([Ca2+]c = 0 
nM) internal solution with (n=17) or without BAPTA (5 mM, n = 13), 177 nM (n = 9) Ca2+ internal solution. Data are 
presented as the percentages of TMRE intensity before CaM application, and values are means ± SEM. * p < 0.05 vs 
Ca2+-free internal solution with BAPTA, by two-way ANOVA and Bonferroni test. 
(B) and (C): Time courses of changes in calcein (B) and DCF (C) signals by CaM with or without intracellular Ca2+. 
Cells were perfused with CaM (●, n = 9-16) in the 177 nM Ca2+ internal solution ([Ca2+]c = 177 nM) or CaM plus 
BAPTA in a Ca2+-free internal solution (△, 5 mM, n = 7-17). Data are presented as the percentages of calcein 
intensity or multiples of DCF intensity before CaM application, and values are means ± SEM. * p < 0.05 vs CaM, by 
two-way ANOVA and Bonferroni test. 
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Figure 5, SR Ca2+ is involved for the effects of CaM on mitochondria.  
Time courses of changes in TMRE (A), calcein (B), and DCF (C) signals by CaM with or without SR Ca2+. 
Permeabilized myocytes were perfused with CaM (■; 10 nM, n = 5-15) in a nominally Ca2+-free ([Ca2+]c =0 nM) 
internal solution. To diminish SR Ca2+, thapsigargin (TG; ▲, 10 μM, n = 8-16) was applied for 15 min before the 
perfusion of CaM. Data are presented as the percentages of TMRE or calcein intensity or multiples of DCF intensity 
before CaM application, and values are means ± SEM. * p < 0.05 vs CaM, by two-way ANOVA and Bonferroni test. 
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Figure 6 Mitochondrial Ca2+ uptake and the effects of CaM on mitochondria.  
(A), (B), and (C) Time courses of changes in TMRE (A), calcein (B) and DCF (C) signals by CaM with or without an 
inhibitor of mitochondrial Ca2+ uniporter, Ru360. CaM (10 nM) was perfused in the 177 nM Ca2+ internal solution (●, 
n = 9-15). Cells were pretreated with Ru360 (10 μM) for 5 min (▼, n = 9-11), and then CaM was perfused in the 
presence of Ru360. Data are presented as the percentages of TMRE or calcein intensity or multiples of DCF intensity 
before CaM application, and values are means ± SEM. * p < 0.05 vs CaM, by two-way ANOVA and Bonferroni test. 
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Figure 7, CaM and mitochondrial Ca2+ concentration 
(A) The 2-D images of rhod-2, Left; before and right; after the application of CaM in a Na+-free ([Na+]c = 0 mM, 
[Ca2+]c = 177 nM) internal solution. (B) The summarized data of the changes in rhod-2 intensity after 20 min 
perfusion of CaM (10 nM). CaM was applied in the control internal solution ([Na+]c = 6 mM, [Ca2+]c = 177 nM) or in 
a Na+-free ([Na+]c = 0 mM, [Ca2+]c = 177 nM) internal solution, where mitoNCX was inhibited. In addition to the 
mitoNCX inhibition, some cells were perfused with TG to eliminate SR Ca2+ releases (CaM + TG). Data are 
presented as the percentages of rhod-2 intensity before CaM application, and values are means ± SEM. * p < 0.05 vs a 
Na+-free internal solution, † p < 0.05 vs 0Na plus CaM by two-way ANOVA and Bonferroni test. (C) Time courses 
of changes in rhod-2 intensity during perfusion of Ru360 in the absence (○, n = 6) or presence (▼, n = 6) of CaM (10 
nM). Cells were pretreated with Ru360 for 5min, and then exposed to CaM. Data are presented as the percentages of 
the baseline rhod-2 intensity, and values are means ± SEM. * p < 0.05 vs CaM, by two-way ANOVA and Bonferroni 
test. 
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Figure legends for supplemental data 
 
 
 
 
Supple Figure 1, Ryanodine inhibited while caffeine enhanced the effects of CaM on mitochondrial membrane 
potential. 
（A）Time courses of the changes in TMRE intensity during the perfusion of CaM (■; 10 nM, n = 16), and CaM 
plus ryanodine (◇; 100 μM, n = 5) in the Ca2+-free ([Ca2+]c = 0 nM) internal solution. In the rynanodine-treated group, 
cells were pretreated with rynanodine for 5 min, and then CaM was applied in the presence of ryanodine. (B) Time 
courses of the changes in TMRE intensity during the perfusion of CaM (●; 10 nM, n = 16), and CaM plus caffeine 
(◆; 1 mM, n = 6) in the 177 nM Ca2+ internal solution. In the caffeine-treated group, cells were pretreated with 
caffeine for 5 min, and then CaM was applied in the presence of caffeine. Data are presented as the percentages of 
calcein intensity before CaM application, and values are means ± SEM. * p < 0.05 vs CaM, † p < 0.05 vs control by 
two-way ANOVA and Bonferroni test. 
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Supple Figure 2, Ca2+ sparks in permeabilized myocytres. 
(A) The line-scan image of resting Ca2+ sparks in permeabilized myocytes. Saponin-permeabilized myocytes 
were perfused with an internal solution, which contained 50 nM Ca2+. (B) Ca2+ spark frequency (CaSPF) in an 
internal solution with 50 nM Ca2+ (open bars; 50 nM, n = 5 cells) or 100 nM Ca2+ (solid bars; 100 nM, n = 6 cells). 
CaSPF (pl-1•s-1) was expressed as the number of Ca2+ sparks per line-scan image after normalization spatially (per 
pico-liter) and temporally (per second). (C) – (E) characteristics of Ca2+ sparks, (C) The amplitude (difference 
between peak spark fluorescence and background fluorescence, ΔF/F0) of Ca sparks, (D) The full-width 
half-maximum (FWHM) of Ca sparks, (E) The full-duration of half maximum (FDHM) of Ca2+ sparks. Two different 
buffered resting [Ca2+]c (open bars; 50 nM, n = 84 sparks, and solid bars; 100 nM n = 194 sparks) were used. The 
detection and analysis of Ca2+ sparks were performed using SparkMaster, a program for automated Ca2+ spark 
analysis. Values are means ± SEM. * p < 0.05 vs 50 nM by unpaired t-test. 
 
